European Society for Medical Oncology.
Professional organisation
- Reports this week
- 0
- Active events
- 5
- Connections
- 74
What's happening
Active this week
-
AstraZeneca presented trial results at the European Society for Medical Oncology (ESMO) Congress in Madrid, Spain.Some support1 report
-
Jian Zhou, President of Zhongshan Hospital and Academician of the Chinese Academy of Sciences, was involved in the ESMO Congress in Madrid.Some support2 reports
-
Bristol-Myers Squibb presented clinical data at the European Society for Medical Oncology (ESMO) Congress in Madrid.Some support4 reports
-
ORIC Pharmaceuticals presented clinical trial data at a medical oncology meeting.Some support1 report
-
Zai Lab presented data at a meeting in Barcelona, involving researcher Pedro Rocha and Amgen.Some support1 report
Earlier this month
-
AstraZeneca presented trial results for its IMFINZI cancer treatment at the European Society for Medical Oncology (ESMO) Congress in Madrid.Some support2 reports
-
Nanobiotix and Jason Chan presented study results at the European Society for Medical Oncology (ESMO) meeting.Some support1 report
-
Zai Lab Limited presented clinical data at the ESMO Congress 2026 in Cambridge, Mass.Some support1 report
-
Abbott presented clinical data and collaborated with Dr. Takayuki Yoshino at the ESMO Congress.Some support1 report
-
Evaxion will present clinical trial data at the ESMO Congress 2025 in Berlin, utilizing therapy from Merck Sharp & Dohme.Some support3 reports
-
Hengrui Pharma and Guangdong Provincial People's Hospital presented research findings at the ESMO Congress on October 20, 2026.Some support1 report
-
Pliant Therapeutics announced its presentation at the European Society for Medical Oncology (ESMO) Congress on October 1, 2026.Some support1 report
-
Study results were presented by Tempus and Pfizer at the ESMO Congress, focusing on ongoing collaboration regarding diagnostic barriers.Some support1 report
-
Calidi Biotherapeutics, Inc. will present posters at the European Society for Medical Oncology (ESMO) Congress in Madrid, Spain.Some support1 report
-
AbbVie presented clinical data at the European Society for Medical Oncology (ESMO) Congress held in Madrid.Some support2 reports
-
Faron Pharmaceuticals presented clinical data at the ESMO Congress on October 19, 2026.Some support1 report
-
Eli Lilly and Company presented oncology data at the European Society for Medical Oncology (ESMO) Congress.Some support5 reports
-
Researchers presented Phase 3 clinical data at the European Society for Medical Oncology (ESMO) Congress on September 21, 2026.Some support1 report1 development inside
-
Eisai presented research at the European Society for Medical Oncology (ESMO) Congress.Some support1 report
One to three months ago
Gone quiet
No new reports in 90+ days-
Insilico Medicine presented Phase 1 data for its ISM6331 drug candidate.Some support2 reports
-
Mabwell presented clinical results at the ESMO Congress, which was hosted by Fudan University Shanghai Cancer Center.Some support4 reports
-
Zymeworks presented data at the ESMO congress and was noted for its listing on Nasdaq amid AI stock competition.Some support3 reports
-
The ESMO Congress was held in Vancouver on June 1, 2026.Well supported3 reports
-
Theriva presented new clinical data at both the ESMO 2025 Congress and the ASCO 2025 Annual Meeting.Some support1 report
-
BioAtla presented data at the ESMO congress held in Barcelona, Spain, on July 3, 2025.Speculative2 reports
-
BriaCell Therapeutics Corp. is presenting clinical data at the ESMO Congress, which is being held in Berlin.Some support3 reports
-
Agenus presented clinical study data on botensilimab and balstilimab at the ESMO Congress in Berlin on July 26, 2025.Some support1 report
-
Immutep accepted abstracts for presentation at the ESMO Congress 2025, which was held in Berlin.Some support1 report
-
Sensei Biotherapeutics presented clinical data at the ESMO Congress on July 30, 2025.Some support1 report
-
NuCana presented at the ESMO Congress 2025, which was held in Berlin.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around European Society for Medical Oncology this week
News at the entities that move European Society for Medical Oncology most-
Eli Lilly and Company OperationalEli Lilly CEO David A. Ricks issued a company statement, coinciding with shares jumping in New York premarket trading.Moves European Society for Medical Oncology
-
Merck KGaA OperationalMerck KGaA acquired Schering-Plough in 2009.Moves European Society for Medical Oncology
-
AstraZeneca OperationalSummit Therapeutics and AstraZeneca announced a partnership on July 4, 2025, to collaborate on lung cancer drug development.Moves European Society for Medical Oncology
-
Tango OperationalUniversity of Georgia adopts Tango Rewards for compensation using Visa cards, alongside a Finance Division task force appointment.Moves European Society for Medical Oncology
-
Tempus OperationalTempus AI and Amazon Web Services are key players in the health tech AI ecosystem.Moves European Society for Medical Oncology
Connections
The 36 strongest of 74, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
AstraZeneca Operational
AstraZeneca presents its drug results at the European Society for Medical Oncology Congress.
-
Eli Lilly and Company Operational
Eli Lilly and Company presents oncology data at the European Society for Medical Oncology Congress.
-
Zai Lab Limited Mentioned together
Zai Lab presented scientific data at the European Society for Medical Oncology Congress.
-
Amgen Shared context
Amgen presented its drug results at the European Society for Medical Oncology Congress.
-
Tango Operational
Tango presented data at a meeting organized by the European Society for Medical Oncology.
-
Eisai Mentioned together
Eisai presents research at the European Society for Medical Oncology Congress.
-
Bioinvent Operational
Bioinvent presented scientific data at the European Society for Medical Oncology Congress.
-
Zymeworks Mentioned together
Zymeworks presented clinical data at the European Society for Medical Oncology Congress.
Show all 36 connections
-
Moderna Shared context
Moderna presents research and trial data at the European Society for Medical Oncology Congress.
-
Charu Aggarwal Operational
Charu Aggarwal presented Phase 3 clinical data at the European Society for Medical Oncology Congress.
-
Guangdong Provincial People's Hospital Mentioned together
Guangdong Provincial People's Hospital presented research findings at the European Society for Medical Oncology Congress.
-
Genmab Operational
Genmab presented its clinical findings at the European Society for Medical Oncology Congress.
-
Vancouver Shared context
The European Society for Medical Oncology held its congress in Vancouver.
-
Madrid Shared context
The European Society for Medical Oncology Congress is held in Madrid.
-
FDA Shared context
The FDA and ESMO shared a professional context as findings were presented at ESMO Congress 2025.
-
BioAtla Shared context
BioAtla presented research and data at the European Society for Medical Oncology congress and meeting.
-
Georgina V. Long Operational
Georgina V. Long presented Phase 3 clinical data at the European Society for Medical Oncology Congress.
-
Berlin Shared context
The European Society for Medical Oncology holds its Congress event in Berlin.
-
Byoung Chul Cho Mentioned together
Byoung Chul Cho participated as a speaker at the European Society for Medical Oncology Congress.
-
Jazz Pharmaceuticals Shared context
Jazz Pharmaceuticals presented clinical trial results at the European Society for Medical Oncology Congress.
-
Özlem Türeci Operational
Özlem Türeci presented late-stage oncology pipeline data at the European Society for Medical Oncology.
-
Bristol-Myers Squibb Shared context
Bristol-Myers Squibb presented clinical data at the European Society for Medical Oncology Congress.
-
Insilico Medicine Shared context
Insilico Medicine presents drug candidate data within the context of the European Society for Medical Oncology.
-
Jason Chan Mentioned together
Jason Chan presented study results at the European Society for Medical Oncology conference.
-
American Society of Clinical Oncology Mentioned together
Two major international medical societies focused on oncology, evidenced by shared professional membership.
-
Akeso Shared context
Akeso presented clinical trial results at the European Society for Medical Oncology conference.
-
AbbVie Shared context
AbbVie presents clinical data at the European Society for Medical Oncology Congress.
-
Barcelona Shared context
The European Society for Medical Oncology holds its congress events in Barcelona.
-
Merck KGaA Operational
Merck KGaA presented scientific data at a meeting organized by the European Society for Medical Oncology.
-
Johnson & Johnson Mentioned together
Johnson & Johnson presents its research results at the European Society for Medical Oncology Congress.
-
Tempus Operational
Tempus presents study results at the European Society for Medical Oncology Congress.
-
Nanobiotix Operational
Nanobiotix presented its research results at the European Society for Medical Oncology meeting.
-
David J. Pinato Shared context
The individual is utilizing the organization's platform to present scientific data at a major medical congress.
-
Hussein Tawbi Mentioned together
Hussein Tawbi presented research results at a conference hosted by the European Society for Medical Oncology.
-
Congress Mentioned together
No direct relationship between Congress and the European Society for Medical Oncology was observed in the evidence.
-
South San Francisco Mentioned together
No evidence of a relationship between European Society for Medical Oncology and South San Francisco was provided.
History
Events by the month they beganOctober 2026
17 events- AstraZeneca presented trial results at the European Society for Medical Oncology (ESMO) Congress in Madrid, Spain.
- Jian Zhou, President of Zhongshan Hospital and Academician of the Chinese Academy of Sciences, was involved in the ESMO Congress in Madrid.
- Bristol-Myers Squibb presented clinical data at the European Society for Medical Oncology (ESMO) Congress in Madrid.
- ORIC Pharmaceuticals presented clinical trial data at a medical oncology meeting.
- Zai Lab presented data at a meeting in Barcelona, involving researcher Pedro Rocha and Amgen.
- AstraZeneca presented trial results for its IMFINZI cancer treatment at the European Society for Medical Oncology (ESMO) Congress in Madrid.
- Nanobiotix and Jason Chan presented study results at the European Society for Medical Oncology (ESMO) meeting.
- Zai Lab Limited presented clinical data at the ESMO Congress 2026 in Cambridge, Mass.
- Abbott presented clinical data and collaborated with Dr. Takayuki Yoshino at the ESMO Congress.
- Hengrui Pharma and Guangdong Provincial People's Hospital presented research findings at the ESMO Congress on October 20, 2026.
- Pliant Therapeutics announced its presentation at the European Society for Medical Oncology (ESMO) Congress on October 1, 2026.
- Study results were presented by Tempus and Pfizer at the ESMO Congress, focusing on ongoing collaboration regarding diagnostic barriers.
- Calidi Biotherapeutics, Inc. will present posters at the European Society for Medical Oncology (ESMO) Congress in Madrid, Spain.
- AbbVie presented clinical data at the European Society for Medical Oncology (ESMO) Congress held in Madrid.
- Faron Pharmaceuticals presented clinical data at the ESMO Congress on October 19, 2026.
- Eli Lilly and Company presented oncology data at the European Society for Medical Oncology (ESMO) Congress.
- Eisai presented research at the European Society for Medical Oncology (ESMO) Congress.
September 2026
2 eventsAugust 2026
1 eventShow 2 earlier months
July 2026
2 eventsJune 2026
10 events- Evaxion will present clinical trial data at the ESMO Congress 2025 in Berlin, utilizing therapy from Merck Sharp & Dohme.
- Zymeworks presented data at the ESMO congress and was noted for its listing on Nasdaq amid AI stock competition.
- The ESMO Congress was held in Vancouver on June 1, 2026.
- Theriva presented new clinical data at both the ESMO 2025 Congress and the ASCO 2025 Annual Meeting.
- BioAtla presented data at the ESMO congress held in Barcelona, Spain, on July 3, 2025.
- BriaCell Therapeutics Corp. is presenting clinical data at the ESMO Congress, which is being held in Berlin.
- Agenus presented clinical study data on botensilimab and balstilimab at the ESMO Congress in Berlin on July 26, 2025.
- Immutep accepted abstracts for presentation at the ESMO Congress 2025, which was held in Berlin.
- Sensei Biotherapeutics presented clinical data at the ESMO Congress on July 30, 2025.
- NuCana presented at the ESMO Congress 2025, which was held in Berlin.